• Je něco špatně v tomto záznamu ?

Short-term Outcomes of Water Vapor Therapy (Rezūm) for BPH/LUTS in the First Czech Cohort

R. Wasserbauer, D. Pacik, G. Varga, V. Vit, J. Jarkovsky, M. Fedorko

. 2021 ; 18 (6) : 699-702. [pub] 20210920

Jazyk angličtina Země Írán

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012204

PURPOSE: To evaluate the short-term results of water vapor therapy (Rezūm) for BPH/LUTS in the first cohort of Czech patients. MATERIALS AND METHODS: Patients with BPH and moderate to severe LUTS (N = 76) who underwent Rezūm treatment from December 2019 to July 2020 were included in the prospective study. Prior to the procedure, they completed the IPSS and OABv8 questionnaires and underwent uroflowmetry, transrectal ultrasound of the prostate, and PSA sampling. The parameters before and 3 months after the procedure were compared and statistically evaluated. RESULTS: The study protocol was completed by 92% of patients (N = 70). We observed a significant increase in Qmax (median 17.7 vs. 8.8 mL/s, P < .001), Qave (9 vs. 4.5 mL/s, P = .001) and voided volume (241 vs. 171 mL, P < .001) and a significant reduction in post-void residual (average 17.5 vs. 67.7 mL), prostate volume (39.3 vs. 62.3 mL) and total PSA (median 1.9 vs. 2.5 ng/mL, resp. P values < .001). There was also a significant decrease in OABv8 score (average 7.6 vs. 16.6, P < .001) and IPSS QoL (1.6 vs. 4.0, P = .037). The improvement in the IPSS score was apparent, yet statistically insignificant (6.8 vs. 16, P = .079). CONCLUSION: Water vapor therapy is an effective and safe method of BPH/LUTS treatment in the short-term.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012204
003      
CZ-PrNML
005      
20220506130954.0
007      
ta
008      
220425s2021 ir f 000 0|eng||
009      
AR
024    7_
$a 10.22037/uj.v18i.6843 $2 doi
035    __
$a (PubMed)34549803
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ir
100    1_
$a Wasserbauer, Roman $u Department of Urology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic. wasserbauer.roman@fnbrno.cz
245    10
$a Short-term Outcomes of Water Vapor Therapy (Rezūm) for BPH/LUTS in the First Czech Cohort / $c R. Wasserbauer, D. Pacik, G. Varga, V. Vit, J. Jarkovsky, M. Fedorko
520    9_
$a PURPOSE: To evaluate the short-term results of water vapor therapy (Rezūm) for BPH/LUTS in the first cohort of Czech patients. MATERIALS AND METHODS: Patients with BPH and moderate to severe LUTS (N = 76) who underwent Rezūm treatment from December 2019 to July 2020 were included in the prospective study. Prior to the procedure, they completed the IPSS and OABv8 questionnaires and underwent uroflowmetry, transrectal ultrasound of the prostate, and PSA sampling. The parameters before and 3 months after the procedure were compared and statistically evaluated. RESULTS: The study protocol was completed by 92% of patients (N = 70). We observed a significant increase in Qmax (median 17.7 vs. 8.8 mL/s, P < .001), Qave (9 vs. 4.5 mL/s, P = .001) and voided volume (241 vs. 171 mL, P < .001) and a significant reduction in post-void residual (average 17.5 vs. 67.7 mL), prostate volume (39.3 vs. 62.3 mL) and total PSA (median 1.9 vs. 2.5 ng/mL, resp. P values < .001). There was also a significant decrease in OABv8 score (average 7.6 vs. 16.6, P < .001) and IPSS QoL (1.6 vs. 4.0, P = .037). The improvement in the IPSS score was apparent, yet statistically insignificant (6.8 vs. 16, P = .079). CONCLUSION: Water vapor therapy is an effective and safe method of BPH/LUTS treatment in the short-term.
650    _2
$a lidé $7 D006801
650    12
$a symptomy dolních močových cest $x etiologie $7 D059411
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    12
$a hyperplazie prostaty $x komplikace $7 D011470
650    _2
$a kvalita života $7 D011788
650    _2
$a pára $7 D013227
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pacik, Dalibor $u Department of Urology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic. dalibor.pacik@gmail.com
700    1_
$a Varga, Gabriel $u Department of Urology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic. varga.gabriel@fnbrno.cz
700    1_
$a Vit, Vitezslav $u Department of Urology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic. vit.vitezslav@fnbrno.cz
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Masaryk University Brno, Kamenice 3, 625 00 Brno, Czech Republic . jaro@sci.muni.cz
700    1_
$a Fedorko, Michal $u Department of Urology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic. fedorko.michal@fnbrno.cz
773    0_
$w MED00177143 $t Urology journal $x 1735-546X $g Roč. 18, č. 6 (2021), s. 699-702
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34549803 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130946 $b ABA008
999    __
$a ok $b bmc $g 1789692 $s 1163405
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 18 $c 6 $d 699-702 $e 20210920 $i 1735-546X $m Urology journal $n Urol J $x MED00177143
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace